Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 AUD | +7.14% | -14.29% | +20.00% |
23/05 | Firebrick Pharma Obtains Nasodine Composition Patent in South Africa | MT |
17/05 | Firebrick Pharma Raises AU$800,000 via Placement | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+20.00% | 77.81L | |
+40.73% | 74TCr | |
+32.83% | 60TCr | |
-6.30% | 35TCr | |
+15.15% | 32TCr | |
+4.05% | 28TCr | |
+15.00% | 24TCr | |
+9.78% | 21TCr | |
-5.52% | 21TCr | |
+6.17% | 16TCr |
- Stock Market
- Equities
- FRE Stock
- News Firebrick Pharma Limited
- Firebrick Pharma Phase 2 Covid-19 Trial Published in Laryngoscope Journal